Close Menu

In a piece she writes for Newsweek, Sharon Begley says NIH's Cancer Genome Atlas "may be fatally flawed." And the price tag for TCGA means that "the atlas threatens to suck up ever-dwindling resources." The article explores the concept of the project and quotes scientists who argue that the its potential gain doesn't come close to justifying its expense.

To read the full story....

...and receive Daily News bulletins.

Already have a GenomeWeb or 360Dx account?
Login Now.

Don't have a GenomeWeb or 360Dx account?
Register for Free.

New analyses indicate the P.1 variant found in Brazil may be able to infect people who have already had COVID-19, the New York Times reports.

According to CNBC, Novavax's CEO says its vaccine could be authorized in the US as early as May.

The US National Institutes of Health has a new initiative to address structural racism in biomedical research.

In PNAS this week: GWAS of TLV-1-associated myelopathy/tropical spastic paraparesis, analysis of twins with hypertrophic cardiomyopathy, and more.